Retraction
microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1
Paper Information
Record ID:
32794
Author(s):
Journal:
Publication Date:
June 28, 2019
Retraction Date:
September 24, 2021
(4.2 years years ago)
Subjects:
Institutions:
- Department of Laboratory, The Third People’s Hospital of Linyi, Linyi, Shandong 276023, People’s Republic of China
- Department of Oncology, The Third People’s Hospital of Linyi, Linyi, Shandong 276023, People’s Republic of China
- Department of Radiation Oncology, Linyi Cancer Hospital, Linyi, Shandong 276000, People’s Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.2147/OTT.S340251Additional Notes:
see also: https://pubpeer.com/publications/3DFA7109A386E1724D495521353478;
Citations (17)
17
Total Citations9
Post-Retraction(52.9%)
8
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
9
Within 1 year
0
After 2+ years
333
Days since retraction (latest)
LncRNA-ENST00000543604 exerts a tumor-promoting effect via miRNA 564/AEG-1 or ZNF326/EMT and predicts the prognosis of and chemotherapeutic effect in colorectal cancer
Weimin Wang, Zhen Zhou, Xiaojun Dai et al. (10 authors)
Frontiers in Oncology
Open Access
Published: Aug 2022
6 citations
6 citations
333 days after retraction
miR-564: A potential regulator of vascular smooth muscle cells and therapeutic target for aortic dissection
Min Li, Yanyan Yang, Jinbao Zong et al. (11 authors)
Journal of Molecular and Cellular Cardiology
Published: Jun 2022
26 citations
26 citations
267 days after retraction
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
Amir Abbas Hamidi, Negin Taghehchian, Zahra Basirat et al. (5 authors)
Biomarker Research
Open Access
Published: Jun 2022
33 citations
33 citations
253 days after retraction
Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
Lina Liu, Yuhong Shi, Lai Qian et al. (11 authors)
Frontiers in Endocrinology
Open Access
Published: May 2022
3 citations
3 citations
229 days after retraction
MicroRNA‐203a‐3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy
Lei Dai, Weidong Zhang, Xianjiang Wu et al. (4 authors)
Journal of Clinical Laboratory Analysis
Open Access
Published: May 2022
8 citations
8 citations
224 days after retraction
MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
Maria Papaioannou, Angeliki Chorti, Anthoula Chatzikyriakidou et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Feb 2022
22 citations
22 citations
132 days after retraction
Noncoding way of the metastasis
Bakiye Göker Bağca, Alican Kuşoğlu, Selin Çeşmeli et al. (4 authors)
Elsevier eBooks
Published: Jan 2022
99 days after retraction
Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation
Rubai Ahmed, Sovan Samanta, Jhimli Banerjee et al. (5 authors)
Current Research in Pharmacology and Drug Discovery
Open Access
Published: Jan 2022
8 citations
8 citations
99 days after retraction
Silencing of circDPP4 suppresses cell progression of human prostate cancer and enhances docetaxel cytotoxicity through regulating the miR‐564/ZIC2 axis
Hao Gu, Zhongqi Duan
The Journal of Gene Medicine
Published: Dec 2021
8 citations
8 citations
81 days after retraction
Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells
Ravneet Chhabra, Stephanie Rockfield, Jennifer Guergues et al. (7 authors)
Scientific Reports
Open Access
Published: Mar 2021
10 citations
10 citations
190 days before retraction
MicroRNA‑564 inhibits the progression of non‑small cell lung cancer via targeting plexin A4
Hui Ding, Liangpeng Li, Biao Gu et al. (5 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Feb 2021
4 citations
4 citations
223 days before retraction
MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020
Liviu Hîțu, Katalin Gábora, Eduard-Alexandru Bonci et al. (7 authors)
Cancers
Open Access
Published: Oct 2020
22 citations
22 citations
334 days before retraction
The role of microRNAs in the pathogenesis of thyroid cancer
Soudeh Ghafouri‐Fard, Zeinab Shirvani-Farsani, Mohammad Taheri
Non-coding RNA Research
Open Access
Published: Jun 2020
59 citations
59 citations
460 days before retraction
Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8
Xu Zha, Xiaoting Xi, Xinyu Fan et al. (6 authors)
Aging
Open Access
Published: May 2020
120 citations
120 citations
508 days before retraction
RETRACTED: KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression
Ying Pu, Juan Xiang, Jiani Zhang
Life Sciences
Published: Mar 2020
13 citations
13 citations
565 days before retraction
MiR-1256 inhibits cell proliferation and cell cycle progression in papillary thyroid cancer by targeting 5-hydroxy tryptamine receptor 3A
Chaowen Wu, Liyuan Ma, Hongfa Wei et al. (6 authors)
Human Cell
Published: Mar 2020
22 citations
22 citations
569 days before retraction
Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2
Zhenglin Wang, Cong Wang, Wei Liu et al. (4 authors)
Experimental and Molecular Pathology
Published: Nov 2019
10 citations
10 citations
679 days before retraction
Quick Stats
Total Citations:
17
Years Since Retraction:
4.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025